MEDICAL

TECHNOLOGIES

TheraSkin

Meshed Bioactive Split-Thickness Skin Allograft

Available via Spartan Medical®’s

VA National IDIQ Contract # 36C10G18D0143
DAPA Agreement # SP0200-19-H-0051

Supporting Product Literature:

Cryopreserved using state of the art quality processes and procedures to maintain living cells, growth factors and the native extracellular matrix scaffold.

  • Scientifically proven to provide the three critical elements to wound healing – All human Extracellular Matrix (ECM), Signaling Molecules (Growth Factors),  & Living Cells (Fibroblasts and Keratinocytes) (Landsman 2016).
  • Published data shows higher % closures vs. other skin substitutes (Towler 2018, Sanders 2014) and with less grafts used (Towler 2018, Sanders 2014).
  • Ability to treat a wide variety of wound types; especially large wounds w/ exposed structures (Gurtner 2019).
  • FDA registered and AATB accredited

All necessary regulatory documentation, instructions for use, published studies, patient education tools, etc. (as applicable) can be provided upon request by contacting cs@spartanmedical.com or (888) 240-8091. We are available at any time to meet with Providers and Staff to answer any questions about Spartan Medical®’s entire portfolio of advanced medical solutions.